62
Participants
Start Date
May 26, 2015
Primary Completion Date
October 31, 2017
Study Completion Date
June 18, 2019
Selumetinib
Pemetrexed
Cisplatin
Carboplatin
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
BCCA - Abbotsford Centre, Abbotsford
BCCA - Vancouver Cancer Centre, Vancouver
Regional Health Authority B, Zone 2, Saint John
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Cancer Centre of Southeastern Ontario at Kingston, Kingston
Lakeridge Health Oshawa, Oshawa
Ottawa Hospital Research Institute, Ottawa
Mount Sinai Hospital, Toronto
University Health Network, Toronto
CHUM - Hopital Notre-Dame, Montreal
Collaborators (1)
AstraZeneca
INDUSTRY
Canadian Cancer Trials Group
NETWORK